The FDA is being taken to task for a failure to include chlorhexidine in its recently announced plan to review the safety of active ingredients in antiseptics used in healthcare.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.